The 9 patient samples were submitted for investigation.Patient (b)(6) is a (b)(6) female.Patient (b)(6) is a (b)(6) male.Patient (b)(6) is a (b)(6) female.The ft4 ii results generated at the customer site for patient id (b)(6), patient id (b)(6), patient id (b)(6), patient id (b)(6), patient id (b)(6) and patient id (b)(6) were confirmed.No interfering factors were identified.The difference of the ft4 ii values generated by different manufacturer's analyzers cannot be explained with available investigation methods.The ft4 ii results generated at the customer site for patient id (b)(6), patient id (b)(6) and patient id (b)(6) were confirmed.Taking into account that these patients are on thyroid medication, the ft4 ii results generated from the roche instrument most likely reflects the anticipated ft4 ii results.
|